Blogs (5)

Mogamulizumab is a Defucosylated Anti-CCR4 Monoclonal Antibody

Mogamulizumab is an Anti-CCR4 monoclonal antibody. It enhances antibody-dependent cellular cytotoxicity and is effective against leukemia.
GR-46611 is a 5-HT1D Receptor Agonist

GR-46611 is a potent 5-HT1D receptor agonist and has the potential for the research of epilepsy and inhibits bladder activity.
Pirarubicin, an Anthracycline Antibiotics, Acts as a Topoisomerase II Inhibitor

Pirarubicin, an anthracycline antibiotics, is a topoisomerase II Inhibitor.
Saracatinib (AZD0530) is a potent Src Family Inhibitor

Saracatinib is a potent Src inhibitor (IC50s of 2.7 to 11 nM for c-Src, Lck, c-YES, Lyn, Fyn, Fgr, and Blk) and has anti-invasive activities.
A Potent and Reversible EGFR Inhibitor (E)-AG 99

(E)-AG 99 is an EGFR inhibitor and shows a growth-inhibition on not only serum-starved cells but also normally grown cells. Treatment for Bladder cancer.

Name
Email *

	Sorry, but the email address you supplied was invalid.